Académique Documents
Professionnel Documents
Culture Documents
Hurting Heart
James T. DeVries, MD
Dartmouth-Hitchcock Medical
Center
Outline
Definitions and scope of problem
Diagnosing and classifying heart failure
Approach to management of CHF
Oral drug therapy (ACE-I, ARB, betablockers,
aldosterone blockade, digoxin)
Device therapy
Biventricular (BiV) pacers
Intracardiac defibrillators (ICDs)
Anatomy 101
Heart Failure
Heart
12
10
10
4.7
3.5
2
0
1991
2000
2037*
Asymptomatic
New York Heart Association/Little Brown and Company, 1964. Adapted from: Farrell MH et al. JAMA. 2002;287:890897.
Pathophysiology
Coronary artery
disease
Hypertension
Diabetes
Myocardial
injury
Pathologic
remodeling
Low ejection
fraction
Cardiomyopathy
Death
Pump
failure
Valvular disease
Neurohormonal
stimulation
Myocardial
toxicity
Symptoms:
Dyspnea
Fatigue
Edema
Chronic
heart
failure
Compensatory Mechanisms:
Renin-Angiotensin-Aldosterone System
Beta
Stimulation
CO
Na+
Renin + Angiotensinogen
Angiotensin I
ACE
Angiotensin II
Peripheral
Vasoconstriction
Kaliuresis
Aldosterone Secretion
Salt & Water Retention
Plasma Volume
Afterload
Cardiac Output
Heart Failure
Fibrosis
Preload
Cardiac Workload
Edema
Drug Therapy
What it
does
Expands blood vessels which
lowers blood pressure,
neurohormonal blockade
ARB (angiotensin
receptor blockers)
Betablocker
Digoxi
n
Diuretic
Aldosterone
blockade
Improve Survival
Betablockers
ACE-inhibitors
Aldosterone blockers
Angiotensin receptor
blockers (ARBs)
Lifestyle Changes
What
Why
Lose weight
Reduce or eliminate
alcohol and caffeine
Quit Smoking
Device Therapy:
Biventricular Pacing
Biventricular Pacing
Ventricular Dysynchrony
Abnormal ventricular conduction resulting
in a mechanical delay and dysynchronous
contraction
25
BiV Pacing
Indications
Defibrillators (ICDs)
Relative Risk
Reduction
Mortality
2 year
ACE-I
23%
27%
-Blockers
35%
12%
Aldosterone
Antagonists
30%
19%
ICD
31%
8.5%
Other Therapies?
Transplant
Artificial hearts
New gadgets to help doctors manage
heart failure
Heart Transplantation
A good solution to the failing heart get a
new heart
Unfortunately we are limited by supply, not
demand
Approximately 2200 transplants are
performed yearly in the US, and this
number has been stable for the past 20
years.
Future Tech
In Summary.
Heart failure is common and has high mortality
Drug therapy improves survival
Betablockers, ACE-I, aldosterone antagonists